5-Nitrothiazol-Clofibric Acid Analogs as Potent Agents Against Nitazoxanide-Resistant Giardia lamblia: Modulation of Glycolytic Genes and Molecular Dynamics Studies
Molecules · 2026
DOI: 10.3390/molecules31172980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Beatriz Hernández-Ochoa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación en Ciencias Ómicas y Epidemiología Microbiana, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico C…. Hauptthemen laut MEDLINE: Giardia lamblia, Thiazoles, Drug Resistance, Glycolysis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Pediatria, Secretaría de Ciencia, Humanidades, Tecnología e Innovación, National Supercomputing Center-IPICYT.
Abstract (Originalsprache)
Giardiasis remains a significant global health issue, and its treatment is increasingly hampered by the emergence of drug resistance and cross-resistance between nitroimidazoles and nitazoxanide. In this study, we evaluated the in vitro antigiardial activity, cytotoxicity, and potential mechanisms of action of seven structural analogs (CLB 1–7) derived from a hybrid structure combining nitazoxanide and clofibric acid. Among them, compounds CLB-3 and CLB-5 emerged as the most potent candidates, demonstrating exceptional efficacy against a nitazoxanide-resistant (NTZr) strain of Giardia lamblia, with potencies up to 43 and 60 times higher than that of the reference drug, respectively. Furthermore, both compounds demonstrated high selectivity for the parasite, exhibiting low cytotoxicity in human Caco-2 cells. To investigate the mechanism of action, functional biochemical assays revealed that treatment with these derivatives significantly reduced the intracellular ATP levels and altered the ADP/ATP ratio, indicating a direct impact on the parasite’s energy metabolism. These functional findings correlate closely with RT-qPCR transcriptional analyses and in silico molecular dynamics simulations; collectively, the data suggest a multi-target mechanism of action that may involve the disruption of energy homeostasis and the possible inhibition of key enzymes in the glycolytic pathway (PFOR, G6PD::6PGL, PK, and PPDK). In summary, these results identify compounds CLB-3 and CLB-5 as highly promising chemotherapeutic candidates for combating refractory giardiasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Investigación en Ciencias Ómicas y Epidemiología Microbiana, Hospital Infantil de México Federico Gómez, Secretaría de Salud, Mexico City 06720, Mexico.
- Departamento de Química, Universidad La Salle, Mexico City 06140, Mexico.
- Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Morelos, Mexico.
- Laboratorio de Biomoléculas y Salud Infantil, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico.
- Neurobiochemistry and Behavior Laboratory, National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez", Mexico City 14269, Mexico.
- Departamento de Química de Biomacromoléculas, Instituto de Química, Universidad Nacional Autónoma de México, México City 04510, Mexico.
ORCID-Profile: Blanca Colin-Lozano, Gabriel Navarrete-Vázquez, Sergio Enríquez-Flores, Ignacio De la Mora-De la Mora, Verónica Pérez de la Cruz, Roberto Arreguin-Espinosa, Rosa Angélica Castillo-Rodríguez, José Antonio Velázquez-Aragón, Noemí Cárdenas-Rodríguez, Cindy Bandala, Abraham Vidal-Limon, Saúl Gómez-Manzo
Förderung
- Instituto Nacional de Pediatria
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- National Supercomputing Center-IPICYT
- Hospital Infantil de México Federico Gómez
- E022 Program, National Institute of Pediatrics, Mexico City, Mexico
- INP
- Fondos Federales
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Ciencia de Frontera 2023
Zitieren
APA
Hernández-Ochoa, B., Colin-Lozano, B., Navarrete-Vázquez, G., Enríquez-Flores, S., De la Mora-De la Mora, I., Pérez de la Cruz, V., Arreguin-Espinosa, R., Castillo-Rodríguez, R. A., Velázquez-Aragón, J. A., Mendoza-Torreblanca, J. G., Cárdenas-Rodríguez, N., Ortega-Cuellar, D., Bandala, C., Vidal-Limon, A., & Gómez-Manzo, S. (2026). 5-Nitrothiazol-Clofibric Acid Analogs as Potent Agents Against Nitazoxanide-Resistant Giardia lamblia: Modulation of Glycolytic Genes and Molecular Dynamics Studies. Molecules. https://doi.org/10.3390/molecules31172980
Vancouver
Hernández-Ochoa B, Colin-Lozano B, Navarrete-Vázquez G, Enríquez-Flores S, De la Mora-De la Mora I, Pérez de la Cruz V, et al. 5-Nitrothiazol-Clofibric Acid Analogs as Potent Agents Against Nitazoxanide-Resistant Giardia lamblia: Modulation of Glycolytic Genes and Molecular Dynamics Studies. Molecules. 2026. doi:10.3390/molecules31172980
BibTeX
@article{HernndezOchoa2026,
author = {Hernández-Ochoa, Beatriz and Colin-Lozano, Blanca and Navarrete-Vázquez, Gabriel and Enríquez-Flores, Sergio and De la Mora-De la Mora, Ignacio and Pérez de la Cruz, Verónica and Arreguin-Espinosa, Roberto and Castillo-Rodríguez, Rosa Angélica and Velázquez-Aragón, José Antonio and Mendoza-Torreblanca, Julieta Griselda and Cárdenas-Rodríguez, Noemí and Ortega-Cuellar, Daniel and Bandala, Cindy and Vidal-Limon, Abraham and Gómez-Manzo, Saúl},
title = {5-Nitrothiazol-Clofibric Acid Analogs as Potent Agents Against Nitazoxanide-Resistant Giardia lamblia: Modulation of Glycolytic Genes and Molecular Dynamics Studies},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31172980}
}
EUVIMED